Caplin Point subsidiary invests in Neoethicals Chile SpA

Caplin Point Laboratories announced today that its material subsidiary, Caplin Point Far East Limited (Hong Kong), has completed an investment in Neoethicals Chile SpA through the purchase of all its shares. The acquisition, approved by the Caplin Point Far East Board on April 1, 2025, aims to establish Neoethicals as a front-end entity for the distribution of Caplin Point Laboratories' products in Chile. The consideration was paid through banking channels by Caplin Point Far East, making Neoethicals a wholly-owned, step-down subsidiary. The cost of acquisition amounted to 3,000 shares at a face value of CLP 1,000 per share, totaling CLP 3,000,000 (equivalent to USD 3,000). Neoethicals Chile SpA, incorporated in 2015, reported a turnover of CLP 278,565,412 (USD 295,222) for CY 2024 and CLP 49,995,906 (USD 59,585) for CY 2023. Caplin Point Laboratories believes this strategic investment will boost its business model and growth potential.